Medical cannabis and its derivatives are gaining increased global recognition for managing various medical conditions [1]. Within dermatology, researchers are exploring how these botanical agents interact with human biology to offer alternatives to conventional treatments [1]. Medicinal cannabis is currently legalized across numerous jurisdictions worldwide, fueling scientific interest in its dermatological applications [1].
The Endocannabinoid System in the Skin
The human skin possesses its own newly discovered endocannabinoid system, which serves as a target network for various natural compounds [1]. When cannabinoids interact with this localized system, they demonstrate distinct biological activities [1]. Studies indicate that these compounds exhibit anti-inflammatory, antipruritic, anti-ageing, and antimalignancy properties through multiple molecular pathways [1]. These unique mechanisms position cannabinoids as a compelling avenue for future dermatological therapies [1].
Potential Applications for Skin Conditions
Scientific literature highlights several skin disorders that may potentially benefit from cannabinoid-based interventions [1]. Researchers have reviewed the pharmacology and clinical use of these compounds for managing acne, atopic dermatitis, psoriasis, skin cancer, pruritus, and localized pain [1]. Furthermore, emerging clinical trials are investigating targeted uses, such as evaluating oral cannabidiol (CBD) therapy to reduce sebum production and improve symptoms of seborrheic dermatitis in patients with Parkinson disease [3].
The Role of Flavonoids in Eczema Management
Beyond cannabis derivatives, other plant-derived molecules are actively investigated for skin health, particularly flavonoids [4]. Eczema is a complex systemic autoimmune disease marked by persistent skin inflammation and associated physical and psychological challenges [4]. While current pharmaceutical options exist, they often yield variable results and carry side effects [4]. Traditional medicinal plants rich in flavonoids are being studied to develop safer, cost-effective prophylactic and therapeutic preparations for atopic eczema [4].
Future Directions and Considerations
While preclinical and clinical findings offer an optimistic outlook, ongoing research is essential to optimize safety, dosages, and administration routes. Natural compounds and plant extracts continue to undergo rigorous evaluation to establish standardized formulations that maximize efficacy while minimizing adverse effects [4]. Collaboration among researchers, clinicians, and pharmaceutical developers remains vital for translating these botanical discoveries into approved clinical treatments.
Sources
- [1] The potential role of cannabinoids in dermatology
- [2] Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders
- [3] Oral Cannabidiol for Seborrheic Dermatitis in Patients With Parkinson Disease: Randomized Clinical Trial
- [4] Flavonoids as Potential Natural Compounds for the Prevention and Treatment of Eczema
- [5] Cannabidiol and Other Cannabinoids in Demyelinating Diseases
- [6] Efficacy and safety of cannabinoids in the treatment of spasticity in multiple sclerosis: A systematic review of randomized clinical trials
- [7] Natural Products for the Management of Asthma and COPD
- [8] Is There a Place for Cannabinoids in Asthma Treatment?